NEW YORK (GenomeWeb News) – Montreal-based Caprion Proteomics has won a $12.9 million contract from the National Institute of Allergy and Infectious Diseases to research biomarkers for infectious diseases, the company said today.
Under the five-year contract, Caprion will act as one of two NIAID Clinical Proteomics Centers for Infectious Disease and Biodefense.
The company will use its CellCarta protein profiling technology to conduct large-scale applied proteomics projects on human clinical samples.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.